Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
This invention relates to a method of imaging vesicular monoamine transporters and to labeled compounds and pharmaceutical compositions thereof, and methods of making labeled compounds useful in imaging vesicular monoamine transporters. This invention also relates to compounds, and methods of monitoring progression of a disease related to vesicular monoamine transporters.
1. A compound of the formula
or a pharmaceutically acceptable salt thereof.
2. A compound of the formula
or a pharmaceutically acceptable salt thereof.
3. A compound of the formula
or a pharmaceutically acceptable salt thereof.
4. The compound of claim 3 , having no less than about 95% stereochemical purity.
5. A diagnostic composition comprising a labeled compound of formula:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent.
6. A compound of the formula
wherein Ms is methanesulfonyl.
7. A compound of the formula
wherein Ts is p-toluenesulfonyl.
8. A process of making a compound of the formula:
comprising reacting a compound of the formula
with 18 F anion,
wherein Ms is methanesulfonyl and Ts is p-toluenesulfonyl.
9. A method of imaging vesicular monoamine transporters, comprising:
a. introducing into a mammal a detectable quantity of the diagnostic composition of claim 5 ;
b. allowing sufficient time for said labeled compound to become associated with said transporters; and
c. detecting the labeled compound.